Helix BioPharma Corp. Working Capital to Net Assets Ratio
Helix BioPharma Corp. working capital to net assets ratio. Helix BioPharma Corp. (HBP) has a Working Capital to Net Assets ratio of -19.7% as of January 2026. Working capital of CA$-3.03 Million (current assets of CA$135.00K minus current liabilities of CA$3.16 Million) is measured against net assets of CA$15.36 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible net worth ratio of Helix BioPharma Corp. to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Helix BioPharma Corp. (2007–2025)
Working capital to net assets ratio of Helix BioPharma Corp. from 2007 to 2025. This chart shows how Helix BioPharma Corp.'s Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of January 2026, the ratio stands at -19.7%, reflecting working capital of CA$-3.03 Million against net assets of CA$15.36 Million CAD. See operational self-sufficiency of Helix BioPharma Corp. to measure how many days the company can operate on defensive assets alone.
Helix BioPharma Corp. Working Capital to Net Assets Ratio by Year (2007–2025)
Helix BioPharma Corp. working capital to net assets ratio by year from 2007 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Helix BioPharma Corp. from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Helix BioPharma Corp. total assets.
| Year | WC/NA Ratio | Working Capital (CAD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | -18.0% | CA$-2.81 Million | CA$15.59 Million | CA$409.00K | CA$3.22 Million | ▼ -154.7 pp |
| 2024 | 136.7% | CA$-123.00K | CA$-90.00K | CA$1.46 Million | CA$1.58 Million | ▲ +32.6 pp |
| 2023 | 104.0% | CA$-878.00K | CA$-844.00K | CA$996.00K | CA$1.87 Million | ▲ +15.0 pp |
| 2022 | 89.0% | CA$284.00K | CA$319.00K | CA$3.69 Million | CA$3.41 Million | ▲ +99.4 pp |
| 2021 | -10.3% | CA$144.00K | CA$-1.39 Million | CA$4.02 Million | CA$3.87 Million | ▼ -102.1 pp |
| 2020 | 91.7% | CA$2.73 Million | CA$2.98 Million | CA$4.66 Million | CA$1.93 Million | ▼ -16.0 pp |
| 2019 | 107.7% | CA$-3.53 Million | CA$-3.28 Million | CA$687.00K | CA$4.22 Million | ▼ -16.8 pp |
| 2018 | 124.5% | CA$-1.90 Million | CA$-1.53 Million | CA$773.00K | CA$2.67 Million | ▼ -2840.2 pp |
| 2017 | 2964.7% | CA$-504.00K | CA$-17.00K | CA$1.70 Million | CA$2.20 Million | ▲ +2872.1 pp |
| 2016 | 92.6% | CA$2.93 Million | CA$3.16 Million | CA$4.23 Million | CA$1.30 Million | ▼ -2.6 pp |
| 2015 | 95.2% | CA$6.50 Million | CA$6.83 Million | CA$7.47 Million | CA$969.00K | ▲ +1.8 pp |
| 2014 | 93.4% | CA$6.36 Million | CA$6.81 Million | CA$7.41 Million | CA$1.04 Million | ▲ +7.2 pp |
| 2013 | 86.2% | CA$4.24 Million | CA$4.92 Million | CA$5.19 Million | CA$948.00K | ▲ +9.9 pp |
| 2012 | 76.4% | CA$4.75 Million | CA$6.22 Million | CA$6.12 Million | CA$1.37 Million | ▼ -11.7 pp |
| 2011 | 88.0% | CA$19.47 Million | CA$22.11 Million | CA$21.68 Million | CA$2.21 Million | ▲ +3.1 pp |
| 2010 | 84.9% | CA$13.39 Million | CA$15.76 Million | CA$15.67 Million | CA$2.28 Million | ▼ -4.7 pp |
| 2009 | 89.6% | CA$15.30 Million | CA$17.06 Million | CA$17.45 Million | CA$2.16 Million | ▼ -3.7 pp |
| 2008 | 93.4% | CA$19.17 Million | CA$20.52 Million | CA$20.31 Million | CA$1.14 Million | ▲ +3.3 pp |
| 2007 | 90.1% | CA$11.47 Million | CA$12.73 Million | CA$13.01 Million | CA$1.54 Million | — |